BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 24091153)

  • 1. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
    Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
    Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
    Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
    Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
    Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
    Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
    Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
    Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
    Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
    Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
    Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
    Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
    Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin.
    Pourjavadi A; Hosseini SH; Alizadeh M; Bennett C
    Colloids Surf B Biointerfaces; 2014 Apr; 116():49-54. PubMed ID: 24441180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
    Quinto CA; Mohindra P; Tong S; Bao G
    Nanoscale; 2015 Aug; 7(29):12728-36. PubMed ID: 26154916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.
    Tao C; Zhu Y
    Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanospheres for co-delivery of methotrexate and mild hyperthermia to colon cancer cells.
    Costa Lima SA; Gaspar A; Reis S; Durães L
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1420-1426. PubMed ID: 28415433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.
    Nowicka AM; Kowalczyk A; Jarzebinska A; Donten M; Krysinski P; Stojek Z; Augustin E; Mazerska Z
    Biomacromolecules; 2013 Mar; 14(3):828-33. PubMed ID: 23327587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
    Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
    Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene glycol modified ORMOSIL theranostic nanoparticles for triggered doxorubicin release and deep drug delivery into ovarian cancer spheroids.
    Nagesetti A; Srinivasan S; McGoron AJ
    J Photochem Photobiol B; 2017 Sep; 174():209-216. PubMed ID: 28800509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
    Chen W; Cheng CA; Zink JI
    ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle-like polypyrrole hollow nanocapsules as multifunctional platforms for highly effective chemo-photothermal combination therapy of cancer cells in vivo.
    Wang Y; Xiao Y; Tang R
    Chemistry; 2014 Sep; 20(37):11826-34. PubMed ID: 25077695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S
    Chem Biol Drug Des; 2013 Sep; 82(3):296-306. PubMed ID: 23594157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
    Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
    J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.